Drugs / MF59-eH5N1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00481065 | Apr 2007 → Dec 2008 | avian influenza | Novartis | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MF59-eH5N1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00481065 ↗ |
| Modality | Vaccine | “MF59-adjuvanted A/H5N1 influenza vaccines” PMID 21606530 ↗ Jun 2011 |